Pathogenica Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Pathogenica Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011004
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pathogenica Inc (Pathogenica) is a medical device company that offers multiplex bacterial detection and genotyping kit. The company provides medical diagnostic sequencing products and services for research and clinical use. Its scientific consulting services offers experimental design, DxSeqTM probe design, and reagents for next-generation sequencing. Pathogenica specializes in DNA sequencing technology for rapid multiplex identification of pathogens, drug resistance genes and toxins in patient samples. The company’s technology enables the selection and sequencing of genomic regions from any number of organism. Its kits are used for deducting nosocomial infections. The company conducts research projects for pharmaceutical, agricultural, and public health customers. Pathogenica is headquartered in Boston, Massachusetts, the US.

Pathogenica Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pathogenica Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pathogenica Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pathogenica Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pathogenica Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Pathogenica Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pathogenica Inc, Medical Equipment, Deal Details 10
Partnerships 10
Pathogenica Enters Into Co-Marketing Agreement With Illumina 10
Pathogenica And Targeted Genomics Enter Into Agreement To Distribute HAI Sequencing Technology 11
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 12
Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 13
Pathogenica Inc – Key Competitors 14
Pathogenica Inc – Key Employees 15
Pathogenica Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Pathogenica Inc, Medical Equipment, Key Facts 2
Pathogenica Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Pathogenica Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pathogenica Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pathogenica Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pathogenica Inc, Deals By Market, 2011 to YTD 2017 8
Pathogenica Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pathogenica Enters Into Co-Marketing Agreement With Illumina 10
Pathogenica And Targeted Genomics Enter Into Agreement To Distribute HAI Sequencing Technology 11
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 12
Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 13
Pathogenica Inc, Key Competitors 14
Pathogenica Inc, Key Employees 15

★海外企業調査レポート[Pathogenica Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biofrontera AG (B8F):企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genmab AS (GEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Genmab A/S (Genmab) is a biotechnology company that develops differentiated human antibody therapeutics for the treatment of cancer. The company's marketed antibody, ofatumumab (Arzerra) and Daratumumab (Darzalex) are indicated for the treatment of chronic lymphocytic leukemia and multiple m …
  • Barclays Bank of Kenya Ltd:企業の戦略・SWOT・財務分析
    Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • AccuVein Inc:医療機器:M&Aディール及び事業提携情報
    Summary AccuVein Inc (AccuVein) is a medical device company that provides medical imaging solutions. The company’s products include AV400 vein viewing system, HF470 extended reach powered wheeled stand, HF450 unpowered wheeled stand, and HF410 hands-free solution. Its AV400 vein viewing system digit …
  • Ping An Insurance (Group) Company of China, Ltd.:企業の戦略・SWOT・財務情報
    Ping An Insurance (Group) Company of China, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ping An Insurance (Group) Company of China, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Charkit Chemical Company LLC:企業の戦略・SWOT・財務情報
    Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report Summary Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Eupraxia Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eupraxia Pharmaceuticals Inc (Eupraxia Pharma) is a drug development company that offers pain management solutions. The company’s technology encapsulates pharmaceutical micro particles in a polymer shell which helps to extend drug release from days to months. Its pipeline products include EP …
  • National Industrialization Co (2060):企業の財務・戦略的SWOT分析
    National Industrialization Co (2060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Swisscom, Ltd.:企業のM&A・事業提携・投資動向
    Swisscom, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swisscom, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Otonomy Inc (OTIC):企業の財務・戦略的SWOT分析
    Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Public Joint-Stock Company Commercial Bank PrivatBank:企業の戦略・SWOT・財務情報
    Public Joint-Stock Company Commercial Bank PrivatBank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank PrivatBank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • First Financial Bancorp:企業の戦略・SWOT・財務情報
    First Financial Bancorp - Strategy, SWOT and Corporate Finance Report Summary First Financial Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Saudi Telecom Co (7010):企業の財務・戦略的SWOT分析
    Saudi Telecom Co (7010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • The Chugoku Electric Power Co., Inc.:企業の戦略・SWOT・財務情報
    The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Lundin Petroleum AB (LUPE):企業の財務・戦略的SWOT分析
    Summary Lundin Petroleum AB (Lundin Petroleum) is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in Norway. The company identifies and matures exploration targets, drill exploration wells, appraise discoveries, and …
  • Explaurum Ltd (EXU):企業の財務・戦略的SWOT分析
    Summary Explaurum Ltd (Explaurum) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of precious and base metals deposits. It explores for copper, gold, silver, zinc, molybdenum, lead, tin, phosphates, aluminium, uranium and …
  • B. Braun Melsungen AG:戦略・SWOT・企業財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Martindale Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Martindale Pharmaceuticals Ltd (Martindale), a subsidiary of Cardinal Health Inc is a pharmaceutical company that offers formulations. The company provides hospital-initiated medicines in emergency medicine and differentiated products in complex neurological conditions,opioid addiction and p …
  • High Peak Royalties Ltd (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Ltd (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆